Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

BARDA exercises additional contract funding for AEOL-10150

July 1, 2015

NIAAA initiates trial of Horizant for alcohol use disorder

June 29, 2015

Laboratorio Farmaceutico CT patents gamma-hydroxybutyric acid prodrugs

June 22, 2015

Pre-EUA dossier for Cleveland Biolabs' entolimod submitted to FDA

June 16, 2015

Probuphine noninferior to sublingual buprenorphine in phase III trial in opioid dependence

June 9, 2015

AEOL-10150 doubles survival in primate model of radiation-induced lung injury

May 5, 2015

Adapt Pharma successfully completes pharmacokinetic study of intranasal naloxone

April 24, 2015

FDA approves filgrastim for myelosuppression in acute radiation injury

April 23, 2015

Tamoxifen found to inhibit the effects of amphetamine

April 21, 2015

Northeastern University patents CB1 receptor modulators

March 12, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...